Autophagy in Osteosarcoma

被引:10
|
作者
Nehme, Grace [1 ]
Gordon, Nancy [1 ]
机构
[1] Univ Texas MD Anderson Canc Ctr, Dept Pediat Res, Houston, TX 77030 USA
来源
CURRENT ADVANCES IN THE SCIENCE OF OSTEOSARCOMA: RESEARCH PERSPECTIVES: TUMOR BIOLOGY, ORGAN MICROENVIRONMENT, POTENTIAL NEW THERAPEUTIC TARGETS, AND CANINE MODELS, 2ND EDITION | 2020年 / 1258卷
关键词
Autophagy; Osteosarcoma; Chemotherapy; Survival; Death; PROMOTES DRUG-RESISTANCE; CELL-DEATH; EPIGENETIC CONTROL; DUAL ROLE; CANCER; INHIBITOR; APOPTOSIS; HYDROXYCHLOROQUINE; TEMOZOLOMIDE; ACTIVATION;
D O I
10.1007/978-3-030-43085-6_11
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Osteosarcoma (OS) remains a difficult disease to treat. The standard chemotherapy regimen has not improved survival for the past three decades. Resistance to chemotherapy remains a challenge and constitutes a major concern to clinical investigators. Autophagy has been recognized as a survival mechanism implicated in resistance to chemotherapy. We previously demonstrated chemotherapy to induce autophagy in OS. However, whether induction of autophagy will lead to survival or death has been the focus of many laboratories. Autophagy is a very context-dependent process, and no specific biomarker has been identified to define whether the process will lead to survival or death. In the present chapter, we present some of the mechanisms involved in the process of autophagy and summarize some of the most recent work related to autophagy in OS and the challenges encountered with the use of old and new autophagy inhibitors.
引用
收藏
页码:167 / 175
页数:9
相关论文
共 50 条
  • [31] Autophagy Blockage Enhances Radiosensitivity of Osteosarcoma MG-63 Cells In Vitro
    Ding, Liangjia
    Ma, Gang
    Liu, Yingli
    Jia, Yuqin
    Liu, Xiaomin
    CLINICAL LABORATORY, 2015, 61 (10) : 1365 - 1372
  • [32] Gemcitabine and Rapamycin Exhibit Additive Effect against Osteosarcoma by Targeting Autophagy and Apoptosis
    Ando, Takashi
    Ichikawa, Jiro
    Fujimaki, Taro
    Taniguchi, Naofumi
    Takayama, Yoshihiro
    Haro, Hirotaka
    CANCERS, 2020, 12 (11) : 1 - 20
  • [33] Cardiomyocyte apoptosis vs autophagy with prolonged doxorubicin treatment: comparison with osteosarcoma cells
    Tacar, Oktay
    Indumathy, Sivanjah
    Tan, Mei Lin
    Baindur-Hudson, Swati
    Friedhuber, Anna M.
    Dass, Crispin R.
    JOURNAL OF PHARMACY AND PHARMACOLOGY, 2015, 67 (02) : 231 - 243
  • [34] Blocked Autophagy by miR-101 Enhances Osteosarcoma Cell Chemosensitivity In Vitro
    Chang, Zhiqiang
    Huo, Lifeng
    Li, Kun
    Wu, Yiming
    Hu, Zhenming
    SCIENTIFIC WORLD JOURNAL, 2014,
  • [35] Targeting HMGB1-mediated autophagy as a novel therapeutic strategy for osteosarcoma
    Huang, Jun
    Liu, Ke
    Yu, Yan
    Xie, Min
    Kang, Rui
    Vernon, Philip
    Cao, Lizhi
    Tang, Daolin
    Ni, Jiangdong
    AUTOPHAGY, 2012, 8 (02) : 275 - 277
  • [36] Autophagy Modulation as a Potential Therapeutic Strategy in Osteosarcoma: Current Insights and Future Perspectives
    Almansa-Gomez, Sergio
    Prieto-Ruiz, Francisco
    Cansado, Jose
    Madrid, Marisa
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (18)
  • [37] MicroRNA-30a Inhibits Proliferation and Metastasis of Osteosarcoma Cells by Modulating Autophagy
    Yuan, Tongzhou
    Wang, Juan
    Wei, Xincheng
    Wang, Guodong
    Xu, Nuo
    Fan, Lei
    JOURNAL OF BIOBASED MATERIALS AND BIOENERGY, 2016, 10 (04) : 265 - 271
  • [38] Cytotoxic effects of delphinidin in human osteosarcoma cells
    Lee, Dong-Yeong
    Park, Young-Jin
    Hwang, Sun-Chul
    Kim, Kwang-Dong
    Moon, Dong-Kyu
    Kim, Dong-Hee
    ACTA ORTHOPAEDICA ET TRAUMATOLOGICA TURCICA, 2018, 52 (01) : 58 - 64
  • [39] Effects of butein on human osteosarcoma cell proliferation, apoptosis, and autophagy through oxidative stress
    Zhang, Pei
    Zhang, Jiale
    Quan, Huahong
    Chen, Pengtao
    Wang, Jingcheng
    Liang, Yuan
    HUMAN & EXPERIMENTAL TOXICOLOGY, 2022, 41
  • [40] Expression and Clinical Implication of Autophagy-Associated Protein p62 in Osteosarcoma
    Ma, Hangzhan
    Li, Xiaoyang
    Wang, Jinglu
    Hornicek, Francis J.
    Garbutt, Cassandra C.
    Chang, Xu
    Duan, Zhenfeng
    ONCOLOGY, 2018, 95 (01) : 52 - 60